IRIS UniCatt

Tisi, Maria Chiara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.068
EU - Europa 1.548
AS - Asia 1.121
SA - Sud America 163
Continente sconosciuto - Info sul continente non disponibili 59
AF - Africa 31
OC - Oceania 3
Totale 4.993
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.024
DE - Germania 612
SG - Singapore 428
CN - Cina 352
PL - Polonia 164
SE - Svezia 164
IT - Italia 153
BR - Brasile 132
VN - Vietnam 122
FR - Francia 112
GB - Regno Unito 106
UA - Ucraina 73
IN - India 64
IE - Irlanda 39
FI - Finlandia 37
ID - Indonesia 29
TR - Turchia 26
RU - Federazione Russa 24
BD - Bangladesh 18
CA - Canada 18
JP - Giappone 18
BE - Belgio 13
MX - Messico 10
CI - Costa d'Avorio 8
HK - Hong Kong 8
IQ - Iraq 8
LT - Lituania 8
NL - Olanda 8
PK - Pakistan 8
AR - Argentina 7
AT - Austria 7
ES - Italia 7
SA - Arabia Saudita 7
VE - Venezuela 7
ZA - Sudafrica 7
EC - Ecuador 6
IR - Iran 6
AE - Emirati Arabi Uniti 4
CH - Svizzera 4
CZ - Repubblica Ceca 4
EG - Egitto 4
JM - Giamaica 4
PE - Perù 4
UZ - Uzbekistan 4
AL - Albania 3
IL - Israele 3
MA - Marocco 3
PH - Filippine 3
RO - Romania 3
SV - El Salvador 3
TN - Tunisia 3
CG - Congo 2
CL - Cile 2
DK - Danimarca 2
ET - Etiopia 2
JO - Giordania 2
MY - Malesia 2
NP - Nepal 2
PY - Paraguay 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AM - Armenia 1
AU - Australia 1
AZ - Azerbaigian 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
KE - Kenya 1
KG - Kirghizistan 1
KR - Corea 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PR - Porto Rico 1
PW - Palau 1
Totale 4.934
Salva come PNG Salva come JPEG
Città #
Singapore 254
Chandler 251
Ashburn 182
Warsaw 159
San Jose 128
Fairfield 80
Beijing 75
Jacksonville 67
Ann Arbor 65
New York 65
Nanjing 56
Nürnberg 48
Woodbridge 48
Dearborn 47
San Mateo 41
Hanoi 40
Dublin 39
Los Angeles 39
Munich 39
Wilmington 38
Seattle 36
Houston 35
Frankfurt am Main 33
Cattolica 30
Ho Chi Minh City 30
Jakarta 26
Milan 24
Chicago 23
Lauterbourg 23
Rome 22
The Dalles 22
Bremen 17
Dallas 17
Helsinki 17
Lancaster 17
Nanchang 17
Hefei 16
Tokyo 16
Boston 15
Kunming 15
London 15
Lawrence 14
Cambridge 13
Marseille 13
Moscow 13
Brussels 12
Redmond 12
Redwood City 11
Atlanta 10
Fremont 10
Princeton 10
Santa Clara 10
São Paulo 10
Tianjin 10
Council Bluffs 9
Hyderabad 9
Jiaxing 9
Phoenix 9
Abidjan 8
Elk Grove Village 8
Guangzhou 8
Hangzhou 8
Hong Kong 8
Izmir 8
Salt Lake City 8
Tampa 8
Boardman 7
Brooklyn 7
Buffalo 7
Changsha 7
Norwalk 7
Shanghai 7
Chengdu 6
Mumbai 6
Orem 6
Shenyang 6
Tukwila 6
Alghero 5
Amsterdam 5
Auburn Hills 5
Belo Horizonte 5
Da Nang 5
Düsseldorf 5
Haiphong 5
Hebei 5
Istanbul 5
Jinan 5
Johannesburg 5
Las Vegas 5
Montreal 5
Poplar 5
University Park 5
Zhengzhou 5
Jeddah 4
Kocaeli 4
Leawood 4
Mexico City 4
Romainville 4
Roubaix 4
Turku 4
Totale 2.655
Salva come PNG Salva come JPEG
Nome #
HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN FIRST LINE TREATMENT FOR HIGH-RISK DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) IN THE RITUXIMAB ERA: AN INTENTION TO TREAT-ANALYSIS 438
Vitamin D deficiency and supplementation in patients with aggressive B-cell lymphomas treated with immunochemotherapy 355
Risk factors for venous thromboembolism in patients with lymphoma requiring hospitalization 331
THE PROGNOSTIC ROLE OF EBV IN PERIPHERAL BLOOD OF PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMA 300
Quantification of DAPK1 Promoter Methylation in Bone Marrow and Peripheral Blood as a Follicular Lymphoma Biomarker 284
Interleukin-6 plasma levels are modulated by a polymorphism in the NF-κB1 gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma. 237
Anemia in Diffuse Large B cell Non-Hodgkin Lymphoma: The Role of IL-6, Hepcidin and Erythropoietin 224
Four doses of unpegylated versus one dose of pegylated filgrastim as supportive therapy in R-CHOP-14 for elderly patients with diffuse large B-cell lymphoma 194
Response to 5-azacytidine in a patient with relapsed Hodgkin Lymphoma and a therapy-related myelodysplastic syndrome 184
Whole blood EBV-DNA predicts outcome in diffuse large B-cell lymphoma 177
A Multicenter Real-life Prospective Study of Axicabtagene Ciloleucel versus Tisagenlecleucel Toxicity and Outcomes in Large B-cell Lymphomas 173
Interleukin-6 plasma levels are modulated by a polymorphism in the NF-κB1 gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma 159
Clinical reversible myelopathy in T-cell lymphoblastic lymphoma treated with nelarabine and radiotherapy: report of a case and review of literature of an increasing complication. 158
Intravascular large-B cell lymphoma: when lymphoma is suspected but routine diagnostic work-up is negative. 157
Clinical reversible myelopathy in T-cell lymphoblastic lymphoma treated with nelarabine and radiotherapy: report of a case and review of literature of an increasing complication 157
FDG-PET/CT at the end of immuno-chemotherapy in follicular lymphoma: the prognostic role of the ratio between target lesion and liver SUVmax (rPET) 157
Anemia in diffuse large B-cell non-Hodgkin lymphoma: the role of interleukin-6, hepcidin and erythropoietin. 152
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 149
Small lymphocytic lymphoma in a patient with Fabry disease 144
Invasive fungal infections in chronic lymphoproliferative disorders: A monocentric retrospective study 141
Risk stratification for invasive fungal infections in patients with hematological malignancies: SEIFEM recommendations 134
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 124
Infections in patients with lymphoproliferative diseases treated with targeted agents: SEIFEM multicentric retrospective study 111
Treatment with Idelalisib in Patients with Relapsed or Refractory Follicular Lymphoma: The Observational Italian Multicenter FolIdela Study 107
Time to progression of mantle cell lymphoma after high-dose cytarabine-based regimens defines patients risk for death 104
Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report 102
Rituximab, bendamustine, and cytarabine followed by venetoclax in older patients with high-risk mantle cell lymphoma (FIL_V-RBAC): a multicentre, single-arm, phase 2 study 24
Brexucabtagene autoleucel in-vivo expansion and BTKi refractoriness have a negative influence on progression-free survival in mantle cell lymphoma: Results from CART-SIE study 16
Totale 4.993
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.707
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.707
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022217 0 0 5 5 25 5 12 43 14 17 41 50
2022/2023604 72 83 45 120 28 84 28 51 73 5 9 6
2023/2024236 11 81 4 5 9 43 2 28 1 0 27 25
2024/2025479 16 24 46 26 52 11 27 12 57 43 94 71
2025/20261.303 184 34 103 113 248 88 246 56 91 85 32 23
2026/2027296 94 198 4 0 0 0 0 0 0 0 0 0
Totale 4.993